| Filed On | Filing |
|---|---|
| 10 Apr 2023 |
8-K/A: Other Events
As previously disclosed, Sorrento Therapeutics, Inc. (“Sorrento” or the “Company”) was engaged in arbitration before the American Arbitration Association against NantPharma, LLC (“NantPharma”) relating to NantPharma’s alleged breaches of... |
| 02 Jul 2021 | 8-K/A: Financial Statements and Exhibits |
| 03 Apr 2019 | 8-K/A: Other Events |
| 20 Jan 2017 | 8-K/A: Financial Statements and Exhibits |
| 05 Feb 2016 | 8-K/A: Financial Statements and Exhibits |
| 03 Mar 2014 | 8-K/A: Financial Statements and Exhibits |
| 07 Oct 2013 | 8-K/A: Financial Statements and Exhibits |
| 30 Sep 2013 | 8-K/A: Financial Statements and Exhibits |
| 22 Sep 2009 | 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +4 more |
Loading...
